SCHEMBL6493987

SCHEMBL6493987

C[C@H]1C[C@H](c2c[nH]c3cc(F)ccc23)CCN1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.55
SLC6A4 P31645 4/20 0.55
HTR1D P28221 3/20 0.52
ADRA1D P25100 3/20 0.50
HTR2A P28223 5/20 0.49
HTR7 P34969 3/20 0.49
KCNH2 Q12809 3/20 0.49
ADRA1B P35368 1/20 0.46
OPRM1 P35372 1/20 0.45
OPRL1 P41146 1/20 0.45
HSD11B1 P28845 3/20 0.45
CCR2 P41597 1/20 0.45
HTR1A P08908 2/20 0.44
DRD1 P21728 2/20 0.44
HTR2C P28335 1/20 0.44
DRD3 P35462 1/20 0.44
HTR6 P50406 1/20 0.44
HTR1B P28222 3/20 0.44
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7090614 0.86 DRD2 (0.49) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL6491645 0.86 DRD2 (0.49) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL6184605 0.81 DRD2 (0.61) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL6499646 0.80 SLC6A4 (0.39) DRD2SLC6A4HTR1DHSD11B1CCR2
SCHEMBL6492379 0.79 SLC6A4 (0.38) DRD2SLC6A4HTR1DHSD11B1CCR2
SCHEMBL16802074 0.78 KDM4E (0.69) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL28885288 0.77 DRD2 (0.46) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL18701706 0.76 DRD2 (0.61) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL18324841 0.75 DRD2 (0.60) DRD2SLC6A4HTR1DADRA1DHTR2A
SCHEMBL18324842 0.75 DRD2 (0.66) DRD2SLC6A4HTR1DADRA1DHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6844338-B2 Piperidyindoles as serotonin receptor ligands ELI LILLY AND COMPANY (US) 2005-01-18 US disclosed
US-20030225068-A1 Piperidyindoles as serotonin receptor ligands ELI LILLY AND COMPANY 2003-12-04 US disclosed
EP-1286992-A1 PIPERIDYINDOLES AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY (US) 2003-03-05 EP disclosed
WO-2001087881-A1 PIPERIDYINDOLES AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY (US) 2001-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225068-A1 Piperidyindoles as serotonin receptor ligands CNR1, HTR1D, HTR1A DRD2 16/4885SLC6A4 215/4885HTR1D 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.